Vimarsana
Biggest News Aggregation in the World

Page 3 - Immunic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Inc Today - Breaking & Trending Today

Sweet Financial Partners LLC Purchases New Shares in Immunic, Inc. (NASDAQ:IMUX) - Vimarsana News

Sweet Financial Partners LLC Purchases New Shares in Immunic, Inc. (NASDAQ:IMUX)

Sweet Financial Partners LLC purchased a new stake in Immunic, Inc. (NASDAQ:IMUX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 29,829 shares of the company’s stock, valued at approximately $45,000. Sweet Financial Partners LLC owned 0.07% of Immunic at the […]

Immunic to present data for lead asset vidofludimus calcium from Phase 2 MS and COVID-19 trials - Vimarsana News

Immunic to present data for lead asset vidofludimus calcium from Phase 2 MS and COVID-19 trials

Immunic Inc (NASDAQ:IMUX) announced that it will present data from its Phase 2 CALLIPER and CALVID-1 clinical trials of its lead asset vidofludimus calcium...

Immunic And 2 Other Stocks Under $2 Insiders Are Buying - Fresh Tracks Therapeutics (OTC:FRTX), Immunic (NASDAQ:IMUX) - Vimarsana News

Immunic And 2 Other Stocks Under $2 Insiders Are Buying - Fresh Tracks Therapeutics (OTC:FRTX), Immunic (NASDAQ:IMUX)

The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript - Vimarsana News

Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript

Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51.

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update - Vimarsana News

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update

– Significantly Strengthened Balance Sheet in January 2024 with Execution of Three-Tranche Private Placement of up to $240 Million, Extending Cash Runway Into the Third Quarter of 2025 Based on...